Powell Max Fixes Nasdaq Breach, But Deeper Woes Surface
- Resolution Time: Powell Max resolved the Nasdaq compliance breach in just one week (from February 5 to February 12, 2026).
- Stock Price Issue: The company's stock closed below $1.00 per share for 30 consecutive business days, triggering a second compliance notice.
- Grace Period: Nasdaq granted Powell Max a 180-day grace period (until August 2026) to address the minimum bid price requirement.
Experts would likely conclude that while Powell Max demonstrated agility in resolving its governance issue, the underlying financial struggles and regulatory challenges highlight the critical need for sustained operational improvements and robust compliance measures to maintain its U.S. listing.
Powell Max Fixes Nasdaq Breach, But Deeper Woes Surface
HONG KONG – February 13, 2026 – Powell Max Limited (Nasdaq: PMAX), a Hong Kong-based financial communications provider, announced today it has successfully resolved a critical compliance breach with the Nasdaq Stock Market, narrowly avoiding a potential crisis of investor confidence. In a swift corporate maneuver, the company appointed four new directors to its board and audit committee, satisfying exchange requirements and closing the inquiry. However, the resolution of this governance issue comes just as a separate regulatory notice and underlying financial weaknesses cast a shadow over the company's stability on the U.S. exchange.
A Race Against the Clock: Inside the Compliance Scramble
The compliance drama began quietly but escalated quickly. The initial trigger was the resignation of board and audit committee member Ms. Lee Chern Koay, effective December 31, 2025. Her departure left the company's audit committee with fewer than the three independent members mandated by Nasdaq Listing Rule 5605(c)(2), a cornerstone of corporate governance designed to ensure independent oversight of a company's finances.
On February 5, 2026, the a-shoe-dropped moment arrived in the form of a formal notification from Nasdaq staff, officially stating that Powell Max was out of compliance. This notice started a countdown for the company to rectify the deficiency or face more severe consequences, including potential delisting proceedings.
Powell Max's response was remarkably rapid. Just five days later, on February 10, the company filed a Form 6-K with the U.S. Securities and Exchange Commission, disclosing the appointment of four new individuals to its Board of Directors and, crucially, its Audit Committee: Mr. Andrew Hancox, Mr. Phillip Balatsos, Ms. Caroline Castleforte, and Ms. Lourdes Felix.
This decisive action was enough to appease the exchange. In a letter dated February 12, Nasdaq confirmed that based on the new appointments, Powell Max had regained compliance and the matter was officially closed. The entire episode, from official notification to resolution, was concluded in a mere week, showcasing a responsive, if reactive, governance mechanism.
The New Guardians: Strategic Appointments to Restore Trust
The swift resolution hinged entirely on the qualifications of the new appointees and their ability to meet Nasdaq's stringent independence and financial literacy standards. A closer look at the new directors reveals a strategic effort to install credible, experienced oversight.
Among the appointees, Ms. Lourdes Felix stands out as a particularly strategic choice. With three decades of experience in corporate finance, public accounting, and capital markets, her resume is tailor-made for an audit committee role. Ms. Felix currently serves as CEO and CFO of BioCorRx Inc. and has a deep background in SEC compliance, internal controls under Sarbanes-Oxley (SOX), and managing regulatory filings. Her experience chairing the audit committee at other public companies like La Rosa Holdings Corp. likely provided Nasdaq with significant assurance.
Another key appointee, Mr. Phillip Balatsos, brings over two decades of experience as a senior executive in foreign exchange sales and trading at global institutions like Barclays Capital and Credit Suisse. His current and past service on the boards of other publicly traded companies, including CISO Global, Inc., demonstrates a familiarity with the responsibilities of a director. His presence on the Audit and Compensation Committees for Aspire Biopharma Holdings, Inc. further bolsters the board's financial acumen.
While less public information is available about Mr. Andrew Hancox and Ms. Caroline Castleforte, the collective strength and documented independence of members like Felix and Balatsos were clearly sufficient to satisfy the regulators. The appointments underscore the critical role that experienced, independent directors play in maintaining a company's standing in U.S. capital markets, serving as the first line of defense in corporate governance.
More Than One Fire to Fight: A Pattern of Challenges
While the board celebrated closing the audit committee matter, there was little time to rest. On February 11, 2026, Powell Max received a second, unrelated notice from Nasdaq. This time, the issue was non-compliance with the exchange's minimum bid price requirement, as the company's stock had closed below $1.00 per share for 30 consecutive business days.
The timing of the two notices paints a troubling picture, suggesting that the audit committee vacancy was not an isolated problem but a symptom of broader struggles. The low stock price is directly linked to the company's faltering financial performance. Recent reports, including its H1 2025 results, showed a sharp swing from profit to a significant net loss despite modest revenue growth. Analysts have noted the firm's weak financial health, characterized by declining revenue, sharply negative profitability, and a reliance on external financing.
Nasdaq has granted Powell Max a 180-day grace period, until August 2026, to regain compliance. To do so, its stock must close at or above $1.00 for at least ten consecutive business days. This shifts the company's focus from a quick governance fix to the much harder, long-term challenge of improving its fundamental business operations and restoring investor faith to lift its stock price.
The Tightrope Walk for Foreign Listings
Powell Max's recent ordeal serves as a potent case study for the growing number of international companies, particularly from Hong Kong and greater Asia, flocking to U.S. exchanges. Drawn by the promise of deep liquidity, premium valuations, and access to the world's largest capital market, these firms are increasingly choosing Nasdaq for their initial public offerings.
However, this access comes with a significant trade-off: adherence to a rigorous and actively enforced regulatory framework. The Powell Max situation demonstrates that Nasdaq and the SEC maintain strict oversight on all listed entities, regardless of their headquarters. From corporate governance rules like audit committee composition to fundamental market metrics like minimum bid price, the standards are inflexible.
For other Hong Kong-based firms listed on Nasdaq, the message is clear. Maintaining robust internal controls, a strong and independent board, and consistent financial performance are not just best practices—they are prerequisites for survival. The swiftness with which Nasdaq issued two separate non-compliance notices to Powell Max highlights a regulatory environment with little tolerance for sustained weakness. While the path to a U.S. listing is attractive, the journey to staying listed requires constant vigilance and operational excellence.
